glycyrrhizic acid has been researched along with Adenoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, Q; Chen, X; Harris, RC; Kon, V; Pozzi, A; Shrubsole, MJ; Xu, J; Yao, B; Yin, H; Zhang, MZ; Zheng, W | 1 |
| Harada, K; Ishida, M; Ito, H; Katayama, S; Kawasaki, H; Okubo, M; Shiota, G; Tomie, Y | 1 |
2 other study(ies) available for glycyrrhizic acid and Adenoma
| Article | Year |
|---|---|
Inhibition of 11beta-hydroxysteroid dehydrogenase type II selectively blocks the tumor COX-2 pathway and suppresses colon carcinogenesis in mice and humans.
Topics: 11-beta-Hydroxysteroid Dehydrogenase Type 2; Adenocarcinoma; Adenoma; Animals; Base Sequence; Cell Line, Tumor; Colonic Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Enzyme Inhibitors; Gene Silencing; Genes, APC; Glycyrrhizic Acid; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Models, Biological; Neovascularization, Pathologic; Receptors, Glucocorticoid; RNA, Small Interfering | 2009 |
Inhibition of hepatocellular carcinoma by glycyrrhizin in diethylnitrosamine-treated mice.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Body Weight; Diethylnitrosamine; Disease Models, Animal; Drug Screening Assays, Antitumor; Glycyrrhizic Acid; Hepatitis, Chronic; Hepatitis, Viral, Human; Liver; Liver Function Tests; Liver Neoplasms, Experimental; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Organ Size | 1999 |